Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Glaukos Corporation (GKOS)

Simbol resmi perusahaan Glaukos Corp. (GKOS)

In-house implant production combined with partial outsourcing of testing ensures consistent quality, as evidenced by the quarterly EPS fluctuations on GURU.Markets, where 111.10 reflects the latest metric value. Glaukos Corporation (GKOS) CEO Thomas Burns has successfully protected revenues from reductions in insurance payouts, and the current strategy is based on the global scaling of innovative ophthalmological devices for the treatment of glaucoma.

Glaukos (GKOS) - Wutah bathi resik saben saham sajroning taun lumaku saka 04.07.2022 nganti 17.11.2026

GKOS (Glaukos): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Glaukos Corporation
Barang unggulan glaukos.com

The implementation of innovative stents and pharmaceuticals by Glaukos Corporation (GKOS) is transforming global ophthalmic surgery standards. This metric measures the percentage change in net income per share compared to the same quarter last year. This quarterly EPS trend reflects the efficiency with which the company monetizes its technological superiority. The growth of this metric confirms the business's ability to convert medical innovations into actual revenue. A steady increase in this value strengthens the investment attractiveness of the capital.

Analisis pesaing

Alcon Corp (ALC) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Bausch Health (BLCO)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan apellis.com|Belite Bio (BLTE) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Ocular Pharma (OCUL)|HROW (Harrow) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan VRDN (Viridian Corp)|LENZ Corp (LENZ) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|OCS: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan eyepointpharma.com|KOD: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aldeyra Therapeutics (ALDX)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan KALA|IRD - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan okyopharma.com (OKYO)|Wutah bathi EPS kuartalan Adverum Biotechnologies Inc. (ADVM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan outlooktherapeutics.com OTLK|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Clearside Biomedical, Inc. (CLSD)|NBY - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPRX (kiorapharma.com)|Alimera Sciences (ALIM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Eyenovia Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|GHSI (Guardion Health Sciences) - Wutah bathi EPS kuartalan|Ocuphire Pharma - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OPT (Opthea)